I worry more about FEV-1 because it is the #1 endpoint that regulators accept. Also regulators care FEV-1 at 6 month while Vertex reported average of month 4 and 6. Do you think 6 month is also good?
At the conference they should report FEV-1 from month 6 to 12, which will be interesting to see.
I agree the fev improve,ent must not dissipate, but it doesn't have to increase more and for pricing the decrease in escervations will be hugely important.
and almost no plan will cover so the wait is on for PQRQ to use a gene therapy mist to actually cure CF, not just a little better breathing with Kalydeco.
Either you are ignorant or a short trying to cover. Insurance does cover it, as it must since their is no alternative treatment...and just breathe a little better? You have no idea how horrible cf is or you would never post that and if you do...and had a conscience you would never post that.
I think it is a justified and a very welcome price to get a break from CF. I don't know why Street think drug should be around 150 K? If Ivacaftor is North of 294 K, combination can't be lower than that. It will be unfair to G551 D patient to pay a higher price because they have rare mutation. If combo is less than 294 K, VRTX will have to bring Ivacaftor price down to match, which I doubt going to happen.
Drug companies and their investors deserve rewards because when risk and losses happen, they are the losers and no one else shares the losses like insurance companies, clients or medicare? Look at Incivek and Telazar cases?
What a #$%$....this guy really is! It sure seems that he doesn't know anything about orphan drugs, and their potentials. So, by comparing Kalydeco to Sovaldi, he basically tries to compare apples and oranges!!!!!!!!!!!!!!!!!!! Stupidity at its best!
Ok. Whatever.. LOL. It doesn't matter how much money you make. Your life depends on fleecing on other people.
Forward going earning is expected to be $7.50 EPS i.e PPS $133/ share. De-risked stock. Great stock for day traders and short play for the next 10 day. I am hoping stock will shot up above $140 after Dr. Michael Boyle presentation on Oct 9 th in the NACFC.
You are a FOOL. Do stocks go up every day? What pullback...? The longs here are up pretty well. Your endless drivel is comical.
been there and would never predict a stock that might be on a tear- go to sleep and don't even look at VRTX for the next year
Sentiment: Strong Buy
Vertex has the best crystal library in existence. My bet is that by converting that resource they can become a dominant force. if you don't know what that crystal library means you don't understand the stock. And to get emotional about a stock performance is a tad weird, no?
Sentiment: Strong Buy